10th Tumor Models Summit San Francisco 2026
Wednesday, January 28, 2026 -- Thursday, January 29, 2026, 0800 - 1630
Join the West Coast's premier pharma and biotech gathering, the 10th Tumor Models Summit San Francisco, where innovation meets opportunity in tumor modeling.
As the FDA phases out animal testing requirements and NIH redirects funding away from animal-only studies, the oncology landscape is transforming. Exciting modalities like ADCs, bispecifics, T-cell engagers demand smarter, more predictive models. CRISPR and AI are accelerating patient-derived model development at unprecedented speed.
This meeting unites industry leaders with cutting-edge vendors to navigate this pivotal shift. Network with pioneers shaping the future of optimizing model selection strategy, discover breakthrough technologies, and position your pipeline ahead of the curve. The industry is evolving; the time is now to be part of the conversation.
URLs:
Website: https://go.evvnt.com/3323763-0?pid=2874
Brochure: https://go.evvnt.com/3323763-3?pid=2874
Category: Conferences | Health
Prices:
Drug Developer Pricing - 2 Day Pass (Conference): USD 0.50,
Academic Pricing - 2 Day Pass (Conference): USD 0.50,
Service Provider Pricing - 2 Day Pass (Conference): USD 3799.00
Speakers: Anlu Chen, Senior Scientist, Computational Oncology, Abbvie, Stephanie Casey Parks, Senior Principal Scientist, Amgen, Deepali Sawant, Scientific Associate Director, Amgen, Bo Hu, Scientist, Bristol Myers Squibb, Yan Qu, Scientist, Translational Oncology, Genentech, Jessica Orf, Principal Scientist II, Gilead Sciences, Barbara Sennino, Vice President, Early Development, 3T Biosciences, Timothy Sproul, Director, Atomic AI, Paul Ponath, Principal Scientist, Bolt Biotherapeutics, Nadege Morisot, Director, In Vivo Translational Biology, Earli, Janica Wong, Director, Therapeutic Biology, Generate:Biosciences, Aditi Bapat, Scientist, Discovery, Pheast Therapeutics, Marini Thian, Associate Director, Toxicology, Revolution Medicines, Udaya Rangaswamy, Director, Translational Biology, Rondo Therapeutics, Renu Dhanasekaran, Professor, Stanford University, Nichole Escalante, Senior Scientist and Group Lead, In Vivo Pharmacology and PK, Zymeworks
As the FDA phases out animal testing requirements and NIH redirects funding away from animal-only studies, the oncology landscape is transforming. Exciting modalities like ADCs, bispecifics, T-cell engagers demand smarter, more predictive models. CRISPR and AI are accelerating patient-derived model development at unprecedented speed.
This meeting unites industry leaders with cutting-edge vendors to navigate this pivotal shift. Network with pioneers shaping the future of optimizing model selection strategy, discover breakthrough technologies, and position your pipeline ahead of the curve. The industry is evolving; the time is now to be part of the conversation.
URLs:
Website: https://go.evvnt.com/3323763-0?pid=2874
Brochure: https://go.evvnt.com/3323763-3?pid=2874
Category: Conferences | Health
Prices:
Drug Developer Pricing - 2 Day Pass (Conference): USD 0.50,
Academic Pricing - 2 Day Pass (Conference): USD 0.50,
Service Provider Pricing - 2 Day Pass (Conference): USD 3799.00
Speakers: Anlu Chen, Senior Scientist, Computational Oncology, Abbvie, Stephanie Casey Parks, Senior Principal Scientist, Amgen, Deepali Sawant, Scientific Associate Director, Amgen, Bo Hu, Scientist, Bristol Myers Squibb, Yan Qu, Scientist, Translational Oncology, Genentech, Jessica Orf, Principal Scientist II, Gilead Sciences, Barbara Sennino, Vice President, Early Development, 3T Biosciences, Timothy Sproul, Director, Atomic AI, Paul Ponath, Principal Scientist, Bolt Biotherapeutics, Nadege Morisot, Director, In Vivo Translational Biology, Earli, Janica Wong, Director, Therapeutic Biology, Generate:Biosciences, Aditi Bapat, Scientist, Discovery, Pheast Therapeutics, Marini Thian, Associate Director, Toxicology, Revolution Medicines, Udaya Rangaswamy, Director, Translational Biology, Rondo Therapeutics, Renu Dhanasekaran, Professor, Stanford University, Nichole Escalante, Senior Scientist and Group Lead, In Vivo Pharmacology and PK, Zymeworks
Starting Price Per Person
$ 0.50 USD
Other Information
Where
Hilton San Francisco Financial District
750 Kearny Street
San Francisco California 94108
United States
( Hotel - Resort )
750 Kearny Street
San Francisco California 94108
United States
( Hotel - Resort )
Event Organizer Contact
More Events
Event ID: 260467
Get Events in Your Inbox
We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox